Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

 

Search in our Online Store

Vaccines
Filter     Order     Display # 
Date Item Title
23 May 2007 Enzo Biochem Individualized Oral Immune Regulation Therapy
22 May 2007 Genitope Corporation Initiates Clinical Trial to Evaluate Use of MyVax(R) Personalized Immunotherapy Following Treatment With Rituximab and Chemotherapy for Follicular Non-Hodgkin's Lymphoma
19 May 2007 AVANT's Typhoid Fever Vaccine Demonstrates Excellent Clinical Potential
18 May 2007 Acambis' ACAM2000 receives positive recommendations from Advisory Committee
18 May 2007 Staphylococcus aureus vaccine development on track - safe and immunogenic in Phase I clinical trials
18 May 2007 Data Published in The Lancet Show GARDASIL(R) was 100 Percent Effective in Preventing High-Grade Vulvar and Vaginal Lesions Caused by HPV Types 16 and 18
18 May 2007 Opexa Therapeutics Completes Patient Enrollment in Phase IIb Trial of Tovaxin(TM) for Treatment of Multiple Sclerosis
17 May 2007 Next Generation Nasal Spray Against Influenza: Clinical Phase I Study Started With FLUVACCdelNS1
16 May 2007 Cytos Biotechnology reports positive results from placebo controlled phase IIa study in patients suffering from house dust mite allergy
16 May 2007 In a phase II clinical trial, Curalogic has shown that its grass product is well tolerated without up-dosing
15 May 2007 Vical DNA Vaccine Elicits Lasting Memory T-cell Immune Responses in Humans
12 May 2007 Phase I Trial for ImmunoCellular Therapeutics Brain Tumor Vaccine Commences
12 May 2007 Crucell, AERAS and SATVI Announce Start of Tuberculosis Vaccine Clinical Trial in South Africa six months after launching initial trial in the United States
10 May 2007 Dendreon Receives Complete Response Letter from FDA For Provenge(R) Biologics License Application
10 May 2007 Sinovac Commences Phase II Clinical Trials for Pandemic Influenza Vaccine (H5N1)
10 May 2007 Cell Genesys Provides Update on Clinical Program for GVAX Immunotherapy for Leukemia
09 May 2007 Focetria(R), the Novartis pandemic influenza vaccine, receives European Union approval
04 May 2007 Novavax Reports Positive Pre-Clinical Study Results from Live Virus Challenge to Pandemic Flu Vaccine
04 May 2007 Revolutionary Immunologic Data Explains Function of Diamyd Diabetes Vaccine
04 May 2007 BioMS Medical Completes Patient Recruitment in MINDSET-01 Phase II Relapsing-Remitting Multiple Sclerosis Trial
04 May 2007 Pharmexa starts pivotal phase III trial in the United States
03 May 2007 Nabi Biopharmaceuticals Announces Positive Results of Phase IIb Trial of NicVAX
01 May 2007 Pharmexa and Bavarian Nordic initiates new NIH funded Phase I trial of two HIV vaccines EP1233 and MVA-BN Polytope in combination
01 May 2007 Advaxis Announces Completion of Patient Accrual in Lovaxin C Phase I/II Trial
01 May 2007 Apollo develops needle-free topical vaccine
28 Apr 2007 Optaflu(R), the Novartis cell culture-derived influenza vaccine, receives positive opinion supporting European Union regulatory approval
27 Apr 2007 Iomai Dose-Ranging Trial Demonstrates Needle-Free Patch Vaccine for Travelers' Diarrhea Stimulates Immune Response Even at Low Doses
26 Apr 2007 Novartis expands portfolio of respiratory medicines by acquiring rights to a novel therapeutic vaccine against nicotine addiction
20 Apr 2007 Resistentia Initiates Phase II Clinical Testing of Novel Immunotherapeutic for Allergic Asthma
19 Apr 2007 Favrille Announces Results From Study Showing Enhanced Activity From Insect Cell-Derived Immunotherapy for Lymphoma
18 Apr 2007 Cell Genesys Reports GVAX Immunotherapy for Prostate Cancer Induces a Broad, Patient-Specific Antibody Response
18 Apr 2007 Merck Submits New Cross-Protection Data for GARDASIL(R) to the FDA and Seeks New Indications for Vaginal and Vulvar Cancers
17 Apr 2007 Cervarix(R), GSK cervical cancer candidate vaccine, demonstrates 100 percent protection against precancerous lesions caused by cancer-causing human papillomavirus types 16 & 18 for more than five years
17 Apr 2007 Generex Biotechnology Vaccine Development Programs Presented at the Annual Meeting of the American Association for Cancer Research
17 Apr 2007 Data from Investigator-Sponsored Trial of Oncophage(R) Cancer Vaccine in Glioma Presented at American Association of Neurological Surgeons Annual Meeting
12 Apr 2007 Roche and Transgene enter partnership on therapeutic vaccines against HPV-mediated diseases
06 Apr 2007 BioMS Medicals's Pivotal Multiple Sclerosis Trial Receives Positive Interim Safety Analysis
05 Apr 2007 CytoGenix Announces Successful Testing of synDNA(TM) Vaccine for Avian Influenza Virus
05 Apr 2007 Regulatory approval to start pediatric clinical trials for Japanese Encephalitis (JE) Vaccine in Ind
04 Apr 2007 Cell Genesys Provides Final Median Survival Data From Second Phase 2 Trial of GVAX Immunotherapy for Prostate Cancer
04 Apr 2007 LigoCyte Pharmaceuticals Initiates U.S. Clinical Trial Of Norovirus Vaccine
04 Apr 2007 Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Dose Escalation Trial with Tovaxin(TM) for Multiple Sclerosis
03 Apr 2007 CSL Biotherapies Submits BLA to Introduce Flu Vaccine to U.S. Market
03 Apr 2007 FDA approves accelerated dosing schedule for GlaxoSmithKline's Twinrix(R)
03 Apr 2007 Novavax Vaccine Provides Robust Immune Response, Pre-Clinical Data Show
31 Mar 2007 GlaxoSmithKline files meningococcal conjugate vaccine
30 Mar 2007 GlaxoSmithKline submits biologics license application to US Food and Drug Administration for Cervarix(R)
30 Mar 2007 Dendreon Announces FDA Advisory Committee Reviewed Provenge(R) for Hormone Refractory Prostate Cancer
30 Mar 2007 Mymetics' HIV Vaccine Achieves Research Breakthrough, Eliciting Protective Antibody Response in Mucosal Tissues of Non-Human Primate Model
30 Mar 2007 Baxter Announces Final Phase I/II Data and Initiation of Phase III Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
Results 251 - 300 of 591

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Thrombopoiesis-Stimulating Agents (TPO)

Order Now

Brief Report Series

CD40 and CD40L (CD154) Agonists & Antagonists

Order Now

Subscribe La Merie Biologics